- Home
- ZEPP vs LVTX Comparison
ZEPP vs LVTX Comparison
Compare ZEPP & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZEPP
- LVTX
- Stock Information
- Founded
- ZEPP 2013
- LVTX 2016
- Country
- ZEPP China
- LVTX Netherlands
- Employees
- ZEPP N/A
- LVTX N/A
- Industry
- ZEPP Computer Manufacturing
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- ZEPP Technology
- LVTX Health Care
- Exchange
- ZEPP Nasdaq
- LVTX Nasdaq
- Market Cap
- ZEPP 50.0M
- LVTX 43.9M
- IPO Year
- ZEPP N/A
- LVTX 2021
- Fundamental
- Price
- ZEPP $3.89
- LVTX $1.71
- Analyst Decision
- ZEPP
- LVTX Strong Buy
- Analyst Count
- ZEPP 0
- LVTX 2
- Target Price
- ZEPP N/A
- LVTX $6.00
- AVG Volume (30 Days)
- ZEPP 32.5K
- LVTX 36.4K
- Earning Date
- ZEPP 11-18-2024
- LVTX 11-14-2024
- Dividend Yield
- ZEPP N/A
- LVTX N/A
- EPS Growth
- ZEPP N/A
- LVTX N/A
- EPS
- ZEPP N/A
- LVTX N/A
- Revenue
- ZEPP $237,238,260.00
- LVTX $7,398,000.00
- Revenue This Year
- ZEPP N/A
- LVTX N/A
- Revenue Next Year
- ZEPP $18.83
- LVTX N/A
- P/E Ratio
- ZEPP N/A
- LVTX N/A
- Revenue Growth
- ZEPP N/A
- LVTX N/A
- 52 Week Low
- ZEPP $2.06
- LVTX $1.13
- 52 Week High
- ZEPP $8.40
- LVTX $6.47
- Technical
- Relative Strength Index (RSI)
- ZEPP 61.73
- LVTX 50.23
- Support Level
- ZEPP $3.75
- LVTX $1.58
- Resistance Level
- ZEPP $4.38
- LVTX $1.72
- Average True Range (ATR)
- ZEPP 0.27
- LVTX 0.10
- MACD
- ZEPP 0.03
- LVTX 0.01
- Stochastic Oscillator
- ZEPP 63.97
- LVTX 59.09
About ZEPP Zepp Health Corporation
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in two segments: Xiaomi Wearable Products and Self-branded products & others. The product portfolio includes smartwatches and fitness bands. The majority is from Self-branded products & other segments. It generates majority of the revenue from Xiaomi Wearable Products segment.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.